Liver Biology/Pathobiology

You have full text access to this OnlineOpen article

Single nucleotide polymorphism–mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency†

  1. Shujuan Pan1,
  2. Lu Huang2,
  3. John McPherson4,
  4. Donna Muzny4,
  5. Farshid Rouhani5,
  6. Mark Brantly5,
  7. Richard Gibbs4,
  8. Richard N. Sifers1,2,3,4,‡,*

Article first published online: 19 MAR 2009

DOI: 10.1002/hep.22974

Issue

Hepatology

Hepatology

Volume 50, Issue 1, pages 275–281, July 2009

Additional Information

How to Cite

Pan, S., Huang, L., McPherson, J., Muzny, D., Rouhani, F., Brantly, M., Gibbs, R. and Sifers, R. N. (2009), Single nucleotide polymorphism–mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency. Hepatology, 50: 275–281. doi: 10.1002/hep.22974

Author Information

  1. 1

    Department of Pathology, Baylor College of Medicine, Houston, TX

  2. 2

    Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX

  3. 3

    Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX

  4. 4

    Department of Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX

  5. 5

    Department of Medicine, University of Florida, Gainesville, FL

  1. ‡

    telephone: 713-798-3169

*Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Mailstop BCM315, Houston, TX, 77030

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 23 JUN 2009
  2. Article first published online: 19 MAR 2009
  3. Accepted manuscript online: 19 MAR 2009 12:00AM EST
  4. Manuscript Accepted: 7 MAR 2009
  5. Manuscript Received: 22 AUG 2008

Funded by

  • NIH. Grant Number: DK064232
  • Fernandez Liver Initiative research grant FO3-12 from the Alpha-1 Foundation
  • Alpha-1 Foundation
  • Liver Tissue Cell Distribution System (LTCDS). Grant Number: #N01-DK-7-0004 / HHSN267200700004C
  • Alpha1-Foundation–University of Florida DNA and Tissue Bank

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (647K)

References

  • 1
    Sifers RN, Finegold MJ, Woo SL. Molecular biology and genetics of alpha 1-antitrypsin deficiency. Semin Liver Dis 1992; 12: 301–310.
  • 2
    Lomas DA, Mahadeva R. Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002; 110: 1585–1590.
  • 3
    Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, et al. Structure and variation of human alpha 1-antitrypsin. Nature 1982; 298: 329–334.
  • 4
    Sifers RN, Finegold MJ, Woo SL. Alpha-1-antitrypsin deficiency: accumulation or degradation of mutant variants within the hepatic endoplasmic reticulum. Am J Respir Cell Mol Biol 1989; 1: 341–345.
  • 5
    Graham KS, Le A, Sifers RN. Accumulation of the insoluble PiZ variant of human alpha 1-antitrypsin within the hepatic endoplasmic reticulum does not elevate the steady-state level of grp78/BiP. J Biol Chem 1990; 265: 20463–20468.
  • 6
    Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl 1965; 432: 1–85.
  • 7
    Le A, Graham KS, Sifers RN. Intracellular degradation of the transport-impaired human PiZ alpha 1-antitrypsin variant. Biochemical mapping of the degradative event among compartments of the secretory pathway. J Biol Chem 1990; 265: 14001–14007.
  • 8
    Teckman JH, Perlmutter DH. The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. J Biol Chem 1996; 271: 13215–13220.
  • 9
    Teckman JH, Burrows J, Hidvegi T, Schmidt B, Hale PD, Perlmutter DH. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem 2001; 276: 44865–44872.
  • 10
    McCracken AA, Brodsky JL. Assembly of ER-associated protein degradation in vitro: dependence on cytosol, calnexin, and ATP. J Cell Biol 1996; 132: 291–298.
  • 11
    Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992; 357: 605–607.
  • 12
    Perlmutter DH. Liver injury in alpha 1-antitrypsin deficiency. Clin Liver Dis 2000; 4: 387–408, vi.
  • 13
    Perlmutter DH. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency. Pediatr Res 2006; 60: 233–238.
  • 14
    Kopito RR, Ron D. Conformational disease. Nat Cell Biol 2000; 2: E207–E209.
  • 15
    Sveger T, Eriksson S. The liver in adolescents with alpha 1-antitrypsin deficiency. HEPATOLOGY 1995; 22: 514–517.
  • 16
    Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976; 294: 1316–1321.
  • 17
    Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science 2008; 319: 916–919.
  • 18
    Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter DH. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci U S A 1994; 91: 9014–9018.
  • 19
    Lederkremer GZ, Glickman MH. A window of opportunity: timing protein degradation by trimming of sugars and ubiquitins. Trends Biochem Sci 2005; 30: 297–303.
  • 20
    Cabral CM, Liu Y, Sifers RN. Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem Sci 2001; 26: 619–624.
  • 21
    Liu Y, Choudhury P, Cabral CM, Sifers RN. Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J Biol Chem 1999; 274: 5861–5867.
  • 22
    Avezov E, Frenkel Z, Ehrlich M, Herscovics A, Lederkremer GZ. Endoplasmic reticulum (ER) mannosidase I is compartmentalized and required for N-glycan trimming to Man5–6GlcNAc2 in glycoprotein ER-associated degradation. Mol Biol Cell 2008; 19: 216–225.
  • 23
    Wu Y, Termine DJ, Swulius MT, Moremen KW, Sifers RN. Human endoplasmic reticulum mannosidase I is subject to regulated proteolysis. J Biol Chem 2007; 282: 4841–4849.
  • 24
    Wu Y, Swulius MT, Moremen KW, Sifers RN. Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation. Proc Natl Acad Sci U S A 2003; 100: 8229–8234.
  • 25
    Hosokawa N, Wada I, Hasegawa K, Yorihuzi T, Tremblay LO, Herscovics A, et al. A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep 2001; 2: 415–422.
  • 26
    Chappell S, Hadzic N, Stockley R, Guetta-Baranes T, Morgan K, Kalsheker N. A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease. HEPATOLOGY 2008; 47: 127–132.
    Direct Link:
  • 27
    Demeo DL, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, et al. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol 2008; 38: 114–120.
  • 28
    Teckman JH, An JK, Loethen S, Perlmutter DH. Fasting in alpha1-antitrypsin deficient liver: constitutive [correction of consultative] activation of autophagy. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1156–G1165.
  • 29
    Hidvegi T, Schmidt BZ, Hale P, Perlmutter DH. Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response. J Biol Chem 2005; 280: 39002–39015.
  • 30
    Teckman JH, Perlmutter DH. Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 2000; 279: G961–G974.
View Full Article (HTML) Get PDF (647K)